Net Asset Value (NAV): SEK970 billion at the end of Q4 2024, a decrease of 2% from Q3. Full Year NAV Growth: 20% increase compared to SIXRX's 9% for the same period. Dividend Proposal: SEK5.20 per share, an 8% increase from the previous year. Patricia Industries Total Return: 6% in Q4, with 3% organic sales growth and 11% underlying EBITA growth. Molnlycke Organic Growth: 8% in Q4, with a 1-percentage-point increase in EBITA margin. Listed Companies Total Return: Negative 4% in Q4, outperforming SIXRX's negative 6%. EQT Investments Value Change: Negative 5% in Q4, with fund investments increasing by 5%. Cash Flow from EQT: Positive SEK1 billion in Q4. Leverage: 1.2% in Q4, at the lower end of the policy range. Average Annual Dividend Growth: 9% over the past 10 years. Warning! GuruFocus has detected 6 Warning Sign with IVSBF. Release Date: January 23, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Net asset value grew by 20% for the full year 2024, significantly outperforming the SIXRX index which grew by 9%. Investor AB returned 27% for the year, showcasing strong performance across all business areas. The Board proposed a dividend of SEK5.2, an 8% increase from the previous year, aligning with the company's goal of steadily rising dividends. Patricia Industries reported a 6% total return in Q4, with strong earnings growth and favorable currency effects. Molnlycke achieved 8% organic growth in Q4, with all business areas and major regions contributing positively. Negative Points Net asset value decreased by 2% in Q4, with a total return on the B share of minus 6%, mirroring the SIXRX index. Listed companies, which make up 70% of the portfolio, saw a total return of minus 4% in Q4, with mixed performance across individual companies. BraunAbility and Atlas Antibodies faced weak demand in their respective markets, impacting their Q4 performance. Permobil experienced lower margins due to unspecified extraordinary costs in the quarter. Sarnova faced weaker demand in its cardiac response segment, attributed to high inventories and market destocking. Q & A Highlights Q: Is there anything specific to note about the slightly higher CapEx and lower working capital contribution for Molnlycke in Q4? A: There is nothing specific to comment on regarding the cash flow. It is as you pointed out, lumpy quarter by quarter, but we remain focused on generating good cash conversion over time in Molnlycke. - Christian Cederholm, CEO Q: What is the outlook for acquisitions in Patricia Industries, considering the current market conditions? A: We continue to see a healthy pipeline for add-on investments and remain open to new platform acquisitions. There has been no significant change in market sentiment in the last quarter. - Christian Cederholm, CEO Story Continues Q: How are you navigating potential impacts from global trade policy changes in 2025? A: It's too early to predict outcomes, but this is a high-priority issue for all companies. Tariffs and geopolitical instability, including war and supply chain resilience, are key focus areas. - Christian Cederholm, CEO Q: Can you explain the reasons behind the weaker demand for BraunAbility in Q4? A: The challenging quarter for BraunAbility was due to weaker market demand, influenced by an inflationary US environment affecting both end users and dealers. - Jenny Ashman Haquinius, CFO Q: What is the strategy for capital allocation in light of EQT's increased fund size and potential exit activity? A: We typically invest about 3% in funds that align with our strategy. We have the flexibility to allocate cash flow between our three business areas, and we will continue redeploying into the next fund cycle. - Christian Cederholm, CEO Q: What is driving the sustained high organic growth in Molnlycke, and is it expected to continue? A: The growth is driven by market expansion, competitive product offerings, and a clear go-to-market strategy. We see solid momentum, especially in wound care, and expect this to continue. - Jenny Ashman Haquinius, CFO Q: How does the US market's favorable backdrop influence your future capital allocation strategy? A: While we are eager to deploy capital in all regions, the US market offers strong opportunities with its breadth and depth. We aim to grow existing companies and potentially add new platforms. - Christian Cederholm, CEO Q: What is the split between currency and operating performance for Patricia Industries' 6% performance? A: The 6% growth is primarily driven by currency, particularly the strengthening of the dollar, with a positive contribution from underlying earnings growth. - Jenny Ashman Haquinius, CFO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Investor AB (IVSBF) (Q4 2024) Earnings Call Highlights: Strong Full-Year NAV Growth Amid Mixed ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...